X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES FULFORD INDIA ALKEM LABORATORIES/
FULFORD INDIA
 
P/E (TTM) x - 398.8 - View Chart
P/BV x 6.1 6.2 97.8% View Chart
Dividend Yield % 0.7 0.1 842.2%  

Financials

 ALKEM LABORATORIES   FULFORD INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
FULFORD INDIA
Mar-14
ALKEM LABORATORIES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,589942 168.7%   
Low Rs1,232450 273.8%   
Sales per share (Unadj.) Rs417.5691.4 60.4%  
Earnings per share (Unadj.) Rs56.311.5 491.2%  
Cash flow per share (Unadj.) Rs64.715.4 421.3%  
Dividends per share (Unadj.) Rs12.702.00 635.0%  
Dividend yield (eoy) %0.90.3 313.3%  
Book value per share (Unadj.) Rs292.9380.0 77.1%  
Shares outstanding (eoy) m119.573.90 3,065.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.0 335.6%   
Avg P/E ratio x25.160.7 41.3%  
P/CF ratio (eoy) x21.845.3 48.1%  
Price / Book Value ratio x4.81.8 262.9%  
Dividend payout %22.617.4 129.3%   
Avg Mkt Cap Rs m168,6532,714 6,213.3%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m9,171505 1,816.1%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m49,9152,696 1,851.2%  
Other income Rs m1,645125 1,311.9%   
Total revenues Rs m51,5612,822 1,827.2%   
Gross profit Rs m8,482-46 -18,280.8%  
Depreciation Rs m1,00615 6,617.1%   
Interest Rs m67110 7,058.9%   
Profit before tax Rs m8,45154 15,563.5%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,60610 16,729.2%   
Profit after tax Rs m6,73145 15,058.6%  
Gross profit margin %17.0-1.7 -987.5%  
Effective tax rate %19.017.7 107.5%   
Net profit margin %13.51.7 813.5%  
BALANCE SHEET DATA
Current assets Rs m27,0621,738 1,556.8%   
Current liabilities Rs m15,324545 2,813.2%   
Net working cap to sales %23.544.3 53.1%  
Current ratio x1.83.2 55.3%  
Inventory Days Days6748 137.2%  
Debtors Days Days414 958.9%  
Net fixed assets Rs m12,61012 105,962.2%   
Share capital Rs m23939 613.1%   
"Free" reserves Rs m34,4901,443 2,390.1%   
Net worth Rs m35,0271,482 2,363.5%   
Long term debt Rs m1,2120-   
Total assets Rs m54,3872,077 2,618.9%  
Interest coverage x13.66.7 202.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 70.7%   
Return on assets %13.62.6 521.5%  
Return on equity %19.23.0 637.1%  
Return on capital %24.94.3 577.4%  
Exports to sales %12.90-   
Imports to sales %3.124.5 12.6%   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540659 233.6%   
Fx inflow Rs m6,56317 38,158.7%   
Fx outflow Rs m3,012673 447.4%   
Net fx Rs m3,552-656 -541.4%   
CASH FLOW
From Operations Rs m7,25990 8,065.0%  
From Investments Rs m1,864105 1,782.2%  
From Financial Activity Rs m-9,273-14 65,763.8%  
Net Cashflow Rs m-150181 -83.1%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 33.1 3.8 871.1%  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.2 -  
Shareholders   68,381 4,783 1,429.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  SHASUN PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; ONGC & Bharti Airtel Top Gainers(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading mixed with stocks in the telecom sector and power sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 19, 2019 03:07 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - NATCO PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS